lonafarnib has been researched along with Orphan Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aschenbrenner, DS | 1 |
| Ghosh, S; Raghunath, M; Sinha, JK | 1 |
1 review(s) available for lonafarnib and Orphan Diseases
| Article | Year |
|---|---|
Progeria: a rare genetic premature ageing disorder.
Topics: Aging; Child; Clinical Trials as Topic; Humans; Lamin Type A; Longevity; Mutation; Piperidines; Prenylation; Progeria; Pyridines; Rare Diseases | 2014 |
1 other study(ies) available for lonafarnib and Orphan Diseases
| Article | Year |
|---|---|
New Drugs for Rare Disorders.
Topics: alpha-MSH; Anti-Obesity Agents; Humans; Piperidines; Progeria; Pyridines; Rare Diseases | 2021 |